Bellevue Group AG Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$6.5B
Holdings
161
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (161 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | ZLABZAI LAB LTD | 135,000 | $3.7B | 56.82% | |
| 102 | AZNASTRAZENECA PLC | 51,600 | $3.5B | 53.16% | |
| 103 | SIBNSI-BONE INC | 125,200 | $2.6B | 40.20% | |
| 104 | CVSCVS HEALTH CORP | 31,503 | $2.5B | 38.05% | |
| 105 | MCKMCKESSON CORP | 4,853 | $2.2B | 34.37% | |
| 106 | BIIBBIOGEN INC | 8,485 | $2.2B | 33.59% | |
| 107 | KRTXKARUNA THERAPEUTICS INC | 6,100 | $1.9B | 29.53% | |
| 108 | IQVIQVIA HLGS INC | 8,260 | $1.9B | 29.23% | |
| 109 | RXRXRECURSION PHARMACEUTICALS IN | 174,557 | $1.7B | 26.33% | |
| 110 | KOSKOSMOS ENERGY LTD | 256,500 | $1.7B | 26.33% | |
| 111 | —LABORATORY CORP AMER HLDGS | 7,089 | $1.6B | 24.65% | |
| 112 | CERTCERTARA INC | 91,215 | $1.6B | 24.54% | |
| 113 | CYTKCYTOKINETICS INC | 18,900 | $1.6B | 24.14% | |
| 114 | RYTMRHYTHM PHARMACEUTICALS INC | 32,869 | $1.5B | 23.11% | |
| 115 | ALKSALKERMES PLC | 52,112 | $1.4B | 22.11% | |
| 116 | BBIOBRIDGEBIO PHARMA INC | 33,300 | $1.3B | 20.56% | |
| 117 | SPYSPDR S&P 500 ETF TR | 2,600 | $1.2B | 18.90% | |
| 118 | ZTSZOETIS INC | 5,790 | $1.1B | 17.48% | |
| 119 | ABBVABBVIE INC | 6,727 | $1.0B | 15.95% | |
| 120 | GDXVANECK ETF TRUST | 33,000 | $1.0B | 15.65% | |
| 121 | XENEXENON PHARMACEUTICALS INC | 22,000 | $1.0B | 15.50% | |
| 122 | KRYSKRYSTAL BIOTECH INC | 8,000 | $992.5M | 15.18% | |
| 123 | PCVXVAXCYTE INC | 15,800 | $992.2M | 15.18% | |
| 124 | INBXUSDINHIBRX INC | 24,600 | $934.8M | 14.30% | |
| 125 | GOOGALPHABET INC | 6,000 | $845.6M | 12.93% | |
| 126 | EHCENCOMPASS HEALTH CORP | 11,900 | $794.0M | 12.14% | |
| 127 | PTGXPROTAGONIST THERAPEUTICS INC | 30,000 | $687.9M | 10.52% | |
| 128 | PFEPFIZER INC | 22,868 | $658.4M | 10.07% | |
| 129 | VRDNVIRIDIAN THERAPEUTICS INC | 30,000 | $653.4M | 9.99% | |
| 130 | RCKTROCKET PHARMACEUTICALS INC | 21,000 | $629.4M | 9.63% | |
| 131 | MRUSMERUS N V | 22,700 | $624.3M | 9.55% | |
| 132 | DVAXDYNAVAX TECHNOLOGIES CORP | 43,200 | $603.9M | 9.24% | |
| 133 | VERVVERVE THERAPEUTICS INC | 39,000 | $543.7M | 8.32% | |
| 134 | XOPSPDR SER TR | 3,900 | $533.9M | 8.17% | |
| 135 | GPCRSTRUCTURE THERAPEUTICS INC | 12,300 | $501.3M | 7.67% | |
| 136 | SUPNSUPERNUS PHARMACEUTICALS INC | 15,100 | $437.0M | 6.68% | |
| 137 | DVADAVITA INC | 3,800 | $398.1M | 6.09% | |
| 138 | LULULULULEMON ATHLETICA INC | 770 | $393.7M | 6.02% | |
| 139 | LTHLIFE TIME GROUP HOLDINGS INC | 25,200 | $380.0M | 5.81% | |
| 140 | NKENIKE INC | 3,400 | $369.1M | 5.65% | |
| 141 | BMEABIOMEA FUSION INC | 25,000 | $363.0M | 5.55% | |
| 142 | BCYCBICYCLE THERAPEUTICS PLC | 20,000 | $361.6M | 5.53% | |
| 143 | CAHCARDINAL HEALTH INC | 3,500 | $352.8M | 5.40% | |
| 144 | CCCCC4 THERAPEUTICS INC | 62,000 | $350.3M | 5.36% | |
| 145 | WW6WW INTL INC | 40,000 | $350.0M | 5.35% | |
| 146 | VKTXVIKING THERAPEUTICS INC | 17,500 | $325.7M | 4.98% | |
| 147 | AUTLAUTOLUS THERAPEUTICS PLC | 50,000 | $322.0M | 4.93% | |
| 148 | ETNBGBP89BIO INC | 20,200 | $225.6M | 3.45% | |
| 149 | VTRSVIATRIS INC | 18,003 | $195.0M | 2.98% | |
| 150 | GDXJVANECK ETF TRUST | 5,000 | $189.6M | 2.90% | |
| 151 | MCHIISHARES TR | 4,100 | $167.0M | 2.56% | |
| 152 | AMRXAMNEAL PHARMACEUTICALS INC | 25,470 | $154.6M | 2.36% | |
| 153 | THCTENET HEALTHCARE CORP | 1,447 | $109.3M | 1.67% | |
| 154 | AG8AGILENT TECHNOLOGIES INC | 363 | $50.5M | 0.77% | |
| 155 | QCOMQUALCOMM INC | 347 | $50.2M | 0.77% | |
| 156 | NVDANVIDIA CORPORATION | 99 | $49.0M | 0.75% | |
| 157 | ORCLORACLE CORP | 454 | $47.9M | 0.73% | |
| 158 | MSFTMICROSOFT CORP | 122 | $45.9M | 0.70% | |
| 159 | MTDMETTLER TOLEDO INTERNATIONAL | 25 | $30.3M | 0.46% | |
| 160 | EXAIEUREXSCIENTIA PLC | 1,765 | $11.3M | 0.17% | |
| 161 | IONQIONQ INC | 741 | $9.2M | 0.14% |
PreviousPage 2 of 2